The immune response to SARS-CoV-2 vaccination in older people

Lancet Healthy Longev. 2023 May;4(5):e177-e178. doi: 10.1016/S2666-7568(23)00060-0.

Authors

Giorgio Fedele¹, Annapina Palmieri², Graziano Onder³

Affiliations

¹ Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy. Electronic address: giorgio.fedele@iss.it.
² Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, 00161 Rome, Italy.
³ Fondazione Policlinico Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

PMID: 37148886
DOI: 10.1016/S2666-7568(23)00060-0

No abstract available

Publication types

Comment

MeSH terms

Aged
COVID-19 Vaccines* / therapeutic use
COVID-19* / prevention & control
Humans
Immunity
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines